Study casts doubt on caffeine link to tinnitus
Caffeine abstinence: An ineffective and potentially distressing tinnitus therapy
Researchers carried out the first pseudo-randomised, double-blinded, placebo controlled study of phased caffeine withdrawal and abstention to test for a connection between caffeine consumption and tinnitus. The aim of the study was to provide evidence for therapeutic practice to the tinnitus community.
Sixty-six volunteers who experienced tinnitus and who usually consumed at least 150 mg a day of caffeine took part in a 30-day trial. Their usual caffeinated tea and coffee was replaced with double-blinded supplies, under one of two conditions: usual caffeine consumption followed by phased withdrawal; or phased withdrawal followed by reintroduction then usual caffeine consumption.
The study was designed so that the participants didn't know about the conditions. They knew they would receive caffeine on some days, but not on others, but did not know which days were which. Participants were required to complete a questionnaire to measure their tinnitus three times during the study – at the start, after they had been withdrawn from caffeine for ten days and after they had consumed their normal amount of caffeine for ten days. The participants also kept a very brief record of their tinnitus symptoms each day.
Dr Lindsay St. Claire, Senior Lecturer in the Centre for Hearing and Balance Studies at the University of Bristol, and the lead researcher on the study, said: "With almost 85 per cent of adults in the world consuming caffeine daily, we wanted to challenge the claim that caffeine makes tinnitus worse. Many professionals support caffeine withdrawal as a tinnitus therapy, even though there is a lack of any relevant evidence, and, in fact, acute symptoms of caffeine withdrawal might even make tinnitus worse.
"Many other dietary restrictions are claimed to alleviate tinnitus without the support from controlled studies. Further work in this area would be of great benefit to people with tinnitus and their clinicians."
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.